Drug
Re104 For
Re104 For: highest development phase Phase 2, developed by Reunion Neuroscience Inc. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Reunion Neuroscience Inc
Trials
| Drug | Phase | Indication |
|---|---|---|
| RE104 for Injection NCT07002034 | Phase 2 | Adjustment Disorder |
Latest
No recent events.
Follow Re104 For on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.